FierceBiotech ١٨ ديسمبر ٢٠٢٥ Voyager jettisons 30 employees, Novartis hands back rights to 2 programs
FierceBiotech ٩ ديسمبر ٢٠٢٥ Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Endpoints News ٨ ديسمبر ٢٠٢٥ #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive ٨ ديسمبر ٢٠٢٥ Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive ٢٦ نوفمبر ٢٠٢٥ Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News ٢٤ نوفمبر ٢٠٢٥ #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking
Lonza News ٧ أكتوبر ٢٠٢٥ Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report
Roche Media ٢٦ سبتمبر ٢٠٢٥ Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters #Novartis underline #Trump pharma